John Harris: The Obligations of Society to Science

John Harris FMedSci., B.A., D.Phil. Sir David Alliance Professor of Bioethics Institute of Medicine Law and Bioethics, School of Law University of Manchester Session: Science, Society and Politics (part 1) Title: “The Obligations of Society to Science�? My question is: is there a moral obligation to undertake, support and even to participate in serious scientific

Krishna B. Garg: Do Globalisation and Modern Scientific Developments Pose New Challenges for the Society!

Lecturer/Position/Organization: Krishna B. Garg/Professor/University of Rajasthan, Jaipur – 302004, India Session/Theme: Science, Ethics and the Ethics of Scientific Research Title of the presentation: Do Globalisation and Modern Scientific Developments Pose New Challenges for the Society! It is perhaps proper to club science and technology together for the sake of discussion even if their internal scope

Demetrio Neri: the Italian debate and legislation in a European perspective

Demetrio Neri Stem cell science and policies: the Italian debate and legislation in a European perspective. Introductory remarks. My presentation consists of two sections. In the first section I’ll try to answer to the question which is the issue of this session. Perhaps my answer will sound a bit pessimistic, but what happened at the

Charles H. Baron: Legal Methodologies for Maximizing Freedom of Scientific Research

Lecturer/Position/Organization: Charles H. Baron/Professor/Boston College Law School Session/Theme: Science and Law Title of the presentation: Legal Methodologies for Maximizing Freedom of Scientific Research In the realm of American law, there may be no more quoted statement from a judicial opinion than that of U.S. Supreme Court Justice Louis Brandeis who observed in a 1932 case:

Tiziano Barberi: Impact of open access in biomedical research

Tiziano Barberi (PhD, senior scientist in the laboratory of Stem Cell and Tumor Biology at Memorial Sloan-Kettering Cancer Center, New York) Session: Science, Technology and Economy Round table: Open Access to Science Impact of open access in biomedical research Open access to science comes from one of the initiatives of the Open Society Institute (OSI).

Giulio Cossu: The experience of the Italian referendum on stem cells

Stem Cells and Public Opinion Giulio Cossu (Director, Stem Cell Research Institute Dibit, H. San Raffaele) “The experience of the Italian referendum on stem cells�? It is now approximately one year since a heated and convulse campaign on the referendum started to reach a peak of animosity and verbal violence few days before the selected

Mino Vianello: Le diverse libertà di ricerca

Mino Vianello Facolta’ di Statistica, ” La Sapienza” Descartes Prize E’ naturale, visto il contesto in cui nasce – contesto non solo italiano, anche se in Italia particolarmente scottante dopo l’introduzione d’una legge sulla fecondazione assistita che tocca direttamente il tema della sperimentazione con le cellule staminali embrionali – e’ naturale, dicevo, che quasi implicitamente

Daniel Perry: Regenerative Medicine Under Attack in America: How Scientists and Patients Are Responding

Speaker/Position/Organization Daniel Perry, Past President (2004-2005) and Current Vice President,Coalition for the Advancement of Medical Research (CAMR), USA – Executive Director Alliance for Aging Research Washington, DC Session: Stem Cell Science and Policies (Part I) Friday, Feb. 17, 8:30 AM Title: “Regenerative Medicine Under Attack in America: How Scientists and Patients Are Responding�? Regenerative medicine

Miodrag Stojkovic: Progress in nuclear transfer technique and embryonic stem cell biology: too fast, too scary?

Lecturer/Position/Organization: Prof. Miodrag Stojkovic, Deputy Director, Centre for Stem Cell Biology and Developmental Genetics, University of Newcastle, UK; Deputy Director Principe Felipe Centre, Valencia, Spain Session/Theme: Stem Cells Science and Policies Title of the presentation: Progress in nuclear transfer technique and embryonic stem cell biology: too fast, too scary? Nuclear transfer (NT) technique requires the

Bernard Siegel: Building a Global Constituency for Stem Cell Research

Bernard Siegel, Executive Director, Genetics Policy Institute Building a Global Constituency for Stem Cell Research Scientific developments, as well as controversies, in stem cell research and nuclear transfer continue. As researchers demonstrate the potential of regenerative medicine, politicians and international organizations continue to scrutinize this work, and some seek to limit or ban it. This